Get the Stockscreener App
0.4756
1.12%
-0.0054
After Hours:
.48
0.0044
+0.93%
cbdMD Inc stock is traded at $0.4756, with a volume of 83,685.
It is down -1.12% in the last 24 hours and down -14.77% over the past month.
See More
Previous Close:
$0.481
Open:
$0.4796
24h Volume:
83,685
Relative Volume:
0.40
Market Cap:
$5.33M
Revenue:
$19.98M
Net Income/Loss:
$-2.66M
P/E Ratio:
-1.1637
EPS:
-0.4087
Net Cash Flow:
$-2.65M
1W Performance:
-4.88%
1M Performance:
-14.77%
6M Performance:
-38.07%
1Y Performance:
-33.95%
1-Day Range:
$0.4746
$0.4999
1-Week Range:
$0.4521
$0.52
52-Week Range:
$0.4521
$2.56
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.4756 | 5.66M | 19.98M | -2.66M | -2.65M | -0.4087 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
cbdMD Inc Stock (YCBD) Latest News
Cbdmd Stock Price Forecast. Should You Buy YCBD? - StockInvest.us
cbdMD to buy Twinlab as supplement M&A heats up - SupplySide Supplement Journal
cbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11) - scanx.trade
cbdMD to Acquire Twinlab's Legacy Supplement Brands - nutritionaloutlook.com
cbdMD to Acquire Twinlab Brands, Expanding Consumer Wellness Portfolio - citybiz
CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. - marketscreener.com
cbdMD acquires legacy supplement brand Twinlab - NutraIngredients.com
cbdMD’s Acquisition of Supplement Legacy Brand Twinlab Creates Unique Synergy - WholeFoods Magazine
cbdMD agrees to acquire Twinlab brands - chaindrugreview.com
Twinlab Sets Asset Sale to cbdMD for $3.98 Million; Consideration Goes to Akretive - TradingView
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com Nigeria
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire
cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView
YCBD | cbdMD, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingAnalyst Drop Coverage - siam.in
cbdMD Inc (YCBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
cbdMD Inc (YCBD) Stock News Today - TradingKey
Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5 - Moomoo
YCBD Downgraded by Maxim Group -- Rating Changed to Hold - GuruFocus
Maxim Group Downgrades cbdMD to Hold From Buy - marketscreener.com
Conferencia de resultados del T3 fiscal de 2026 de CBDMD (YCBD): los ingresos aumentan un 20%, objetivo de reducción de costos - TradingKey
YCBD|cbdMD Inc|Price:0.470|Chg%:-0.005 - TradingKey
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance
YCBD Q3 FY2026 earnings call - finance.biggo.com
cbdMD Q3 2026 Earnings Call: Complete Transcript - Benzinga
Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours - Investing.com
Transcript : CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
cbdMD Q3 FY2026 Earnings: Revenue Grows 20% as Gross Margin Narrows - TradingKey
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - PR Newswire
cbdMD, Inc. (NYSE: YCBD) grows sales to $16.2M amid going concern warning - Stock Titan
cbdMD (NYSE American:YCBD): What Does the Latest Update Mean for Brand Demand? - Kalkine Media
cbdMD reports 20% revenue growth in Q3 2026, dr... - Pluang
cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
cbdMD schedules conference call on quarterly results - Bitget
cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan
cbdMD to discuss Q3 2026 financial results in c... - Pluang
cbdMD Inc. (YCBD) Holds Steady at $0.58 as Traders Eye Key $0.55–$0.61 RangeBollinger Walk - dars.gov.et
CBD Gummy Bears Stock SymbolView gF7h08LSE - Diario AS
Senate bill proposes delay of hemp product restrictions By Investing.com - Investing.com UK
cbdMD Inc. (YCBD) Surges 12% to $0.57: Key Levels to WatchChart Pattern Alerts - dars.gov.et
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - TradingView
Cbdmd Cbd Oil Tincture Review: What Customers Are Saying Fall 2026 [WY2QyUdh5WG] - Diario AS
YCBD|cbdMD Inc|Price:0.507|Chg%:+0.034 - TradingKey
cbdMD Inc (YCBD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
cbdMD Inc. (YCBD) Treads Water Near Support Level as Price Ekes Out Slight GainFibonacci Entry Signals - vinanet.vn
cbdMD Inc. (YCBD) Faces Selling Pressure as Stock Tests Key Support LevelsFibonacci Extension - vinanet.vn
cbdMD Inc (YCBD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
cbdMD Inc (YCBD) Valuation: PE, PB & Fair Value Analysis - TradingKey
cbdMD Inc (YCBD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
cbdMD Inc (YCBD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
YCBD|cbdMD Inc|Price:0.538|Chg%:-0.045 - TradingKey
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):